Literature DB >> 20965300

Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.

Yu-Cheng Kao1, Yia-Ping Liu.   

Abstract

BACKGROUND: Personal beliefs about medication compliance have been reliably associated with emotional and behavioral response to mental health problems and health outcomes. This notion has been extensively explored in relation to mental illness. In the current study, a questionnaire designed to assess beliefs about medication compliance (the medication adherence rating scale [MARS]) was translated into Taiwanese to explore beliefs about compliance in schizophrenic patients.
METHODS: In this cross-sectional study, 104 patients who met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria for schizophrenic disorders were recruited and independently interviewed. We first determined the psychometric properties of the translated MARS, including internal consistency, test-retest reliability, and construct validity. In addition, we investigated the relationships between medication compliance and clinical variables through correlation and regression analyses.
RESULTS: We found that the translated MARS was a simple and reliable self-reported compliance scale. Furthermore, in this exploratory study, we found that patients with better medication compliance had better insight into mental illness, less severe psychopathologic condition, and less negative subjective response to side effects of antipsychotics.
CONCLUSIONS: Additional research focusing on these patient outcomes will be of great interest and value in elucidating the role of medication compliance in management of schizophrenic patients.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20965300     DOI: 10.1016/j.comppsych.2010.03.007

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  17 in total

1.  Psychometric properties of the Taiwanese version of the Illness Concept Scale: relation of health beliefs to psychopathology and medication compliance.

Authors:  Yu-Chen Kao; Yia-Ping Liu; Ming-Kuen Chou; Tsung-Hsing Cheng
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-03-04       Impact factor: 4.328

2.  The impact of cognitive insight, self-stigma, and medication compliance on the quality of life in patients with schizophrenia.

Authors:  Yin-Ju Lien; Hsin-An Chang; Yu-Chen Kao; Nian-Sheng Tzeng; Chien-Wen Lu; Ching-Hui Loh
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-07-29       Impact factor: 5.270

3.  The impact of second-generation antipsychotic adherence on positive and negative symptoms in recent-onset schizophrenia.

Authors:  Kenneth L Subotnik; Joseph Ventura; Denise Gretchen-Doorly; Gerhard S Hellemann; Elisha R Agee; Laurie R Casaus; John S Luo; Kathleen F Villa; Keith H Nuechterlein
Journal:  Schizophr Res       Date:  2014-08-06       Impact factor: 4.939

4.  Correlations between awareness of illness (insight) and history of addiction in heroin-addicted patients.

Authors:  Angelo Giovanni Icro Maremmani; Luca Rovai; Fabio Rugani; Matteo Pacini; Francesco Lamanna; Silvia Bacciardi; Giulio Perugi; Joseph Deltito; Liliana Dell'osso; Icro Maremmani
Journal:  Front Psychiatry       Date:  2012-07-09       Impact factor: 4.157

Review 5.  Insight in schizophrenia: relationship to positive, negative and neurocognitive dimensions.

Authors:  Boban Joseph; Janardhanan C Narayanaswamy; Ganesan Venkatasubramanian
Journal:  Indian J Psychol Med       Date:  2015 Jan-Mar

6.  Continue, adjust, or stop antipsychotic medication: developing and user testing an encounter decision aid for people with first-episode and long-term psychosis.

Authors:  Yaara Zisman-Ilani; David Shern; Patricia Deegan; Julie Kreyenbuhl; Lisa Dixon; Robert Drake; William Torrey; Manish Mishra; Ksenia Gorbenko; Glyn Elwyn
Journal:  BMC Psychiatry       Date:  2018-05-22       Impact factor: 3.630

7.  Association between Therapeutic Alliance and Adherence in Outpatient Schizophrenia Patients.

Authors:  Jhin Goo Chang; Daeyoung Roh; Chan-Hyung Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-05-31       Impact factor: 2.582

8.  Mediating Effect Of The Motivation For Medication Use On Disease Management And Medication Adherence Among Community-Dwelling Patients With Schizophrenia.

Authors:  Wen Ling Hsieh; Shih Kai Lee; Wai Tong Chien; Wen I Liu; Chien Yu Lai; Chieh Yu Liu
Journal:  Patient Prefer Adherence       Date:  2019-11-05       Impact factor: 2.711

9.  Development of an Item Bank to Measure Medication Adherence: Systematic Review.

Authors:  Yu Heng Kwan; Livia Jia Yi Oo; Dionne Hui Fang Loh; Truls Østbye; Lian Leng Low; Hayden Barry Bosworth; Julian Thumboo; Jie Kie Phang; Si Dun Weng; Dan V Blalock; Eng Hui Chew; Kai Zhen Yap; Corrinne Yong Koon Tan; Sungwon Yoon; Warren Fong
Journal:  J Med Internet Res       Date:  2020-10-08       Impact factor: 5.428

10.  Smartphone Applications for Educating and Helping Non-motivating Patients Adhere to Medication That Treats Mental Health Conditions: Aims and Functioning.

Authors:  Angelos P Kassianos; Giorgos Georgiou; Electra P Papaconstantinou; Angeliki Detzortzi; Rob Horne
Journal:  Front Psychol       Date:  2017-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.